Trial Profile
A Study to Compare the Efficacy and Safety of Aprepitant with Dexamethasone in Patients with Carboplatin Induced Emesis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Dexamethasone; Granisetron
- Indications Emesis
- Focus Therapeutic Use
- 11 Dec 2015 New trial record